维普期刊资源整合服务平台（V6.5）

维普中文期刊产品整合服务

15篇 您的检索式：作者名="Altaany"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

		题名	作者	年代	出处	被引量
	1	Hydrogen sulfide is an endogenous stimulator of angiogenesis显示文摘	Papapetropoulos A Pyriochou A Altaany Z	2009	Proc Natl Acad Sci U S A2009，106，21：	1
	2	Image Interpolation Using Kriging Technique for Spatial Data显示文摘	Firas Ajil Jassim Fawzi Hasan Altaany	2013	Canadian Journal on Image Processing and Computer Vision2013，4，2：	1
	3	Hydrogen sulfide is an endogenous stimulator of angiogenesis 显示文摘	Papapetropoulos A Pyrioehou A Altaany Z	2009	Proc Natl Acad Sci USA2009，106，21：	1
	4	Hydrogen sulfide is an endogenous stimulator of angiogenesis 显示文摘	Papapetropoulos A Pyriochou A Altaany Z	2009	Proe Natl Aead Sei USA2009，106，21：	1
	5	Crosstalk between hydrogen sulfide and nitric oxide in endothelial cells显示文摘	ALTAANY Z YANG G WANG R	2013	J Cell Mol Med2013，17，7：	1
	6	Hydrogen sulfide is an endogenous stimulator of angiogenesis显示文摘	Papapetropoulos A Pyriochou A Altaany Z		0，，：	1
	7	Hydrogen sulfide and endothelial dysfunction:relationship with nitric oxide显示文摘	Altaany Z Moccia F Munaron L	2014	Curr Med Chem2014，21，32：	1
	8	Hydrogen sul- fide is an endogenous stimulator of angiogenesis 显示文摘	Papapetropoulos A Pyriochou A Altaany Z	2009	Proc Natl Acad Sci USA2009，106，21：	1
	9	Hydrogen sulfide is an endogenous stimulator of angiogenesis显示文摘	Papapetropoulos AI Pyriochou A Altaany Z	2009	Proc Natl Acad Sci USA2009，106，21：	1
	10	Crosstalk between hydrogen sulfide and nitric oxide in endothelial cells显示文摘	Altaany Z Yang G Wang R		0，，07：	1
	11	Hydrogen sulfide is an endogenous stimulator ofangiogenesis显示文摘	Papapetropoulos A Pyriochou A Altaany Z	2009	Proc Natl Acad Sci USA2009，106，21：	1
	12	Hydrogensulfide is an endogenous stimulator of angiogenesis 显示文摘	PapapetropoulosA Pyriochou A Altaany Z	2009	Proc Natl Acad Sci USA2009，106，21：	1
	13	Hydrogen sulfide is an endogenous stimulator of angiogenesis显示文摘	Papapetropoulos A Pyriochou A Altaany Z	2009	Proc Natl Acad Sci USA2009，106，21：	1
	14	Mesenchymal stem cells and COVID-19: What they do and what they can do显示文摘The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) orcoronavirus disease 2019 (COVID-19) pandemic has exhausted the health systemsin many countries with thousands cases diagnosed daily. The currently usedtreatment guideline is to manage the common symptoms like fever and cough,but doesn’t target the virus itself or halts serious complications arising from thisviral infection. Currently, SARS-CoV-2 exhibits many genetic modulations whichhave been associated with the appearance of highly contagious strains. Thenumber of critical cases of COVID-19 increases markedly, and many of theinfected people die as a result of respiratory failure and multiple organ dysfunction. The regenerative potential of mesenchymal stem cells (MSCs) has beenextensively studied and confirmed. The impressive immunomodulation and antiinflammatoryactivity of MSCs have been recognized as a golden opportunity forthe treatment of COVID-19 and its associated complications. Moreover, MSCsregenerative and repairing abilities have been corroborated by many studies withpositive outcomes and high recovery rates. Based on that, MSCs infusion could bean effective mechanism in managing and stemming the serious complications andmultiple organ failure associated with COVID-19. In the present review, wediscuss the commonly reported complications of COVID-19 viral infection and theestablished and anticipated role of MSCs in managing these complications.	Ejlal Abu-El-Rub Ramada R Khasawneh Fatimah Almahasneh Zaid Altaany Nesreen Bataineh Hana Zegallai Saravanan Sekaran	2021	World Journal of Stem Cells2021，13，9：	0
	15	Successful management of life-threatening respiratory failure from H1N1 influenza显示文摘We report the outcome of a pregnant woman with a life-threatening acute respiratory distress syndrome from a novel influenza A(H1N1) virus infection 3 d postpartum successfully managed by veno-arterial extracorporeal membrane oxygenation. The patient was successfully weaned from extracorporeal membrane oxygenation(ECMO) on day 10. Novel H1N1 virus infection was identified by real-time reverse transcriptionpolymerase chain reaction. Veno-arterial ECMO in this patient carried a number of specific advantages namely maintaining haemodynamic stability obviating the need for inotrope support and improving oxygenation compared to alternative approaches such as veno-venous ECMO and pumpless devices. Femoral arterial and venous cannulae were inserted in a pure percutaneous method allowing rapid establishment of extracorporeal circulation. Given the high mortality of acute respiratorydistress syndrome following novel H1N1 virus infection, we advocate the use of ECMO when conventional mechanical ventilation fails.	Nawwar Al-Attar Lila Bouadma Haitham Altaani Michel Wolff Patrick Nataf	2013	World Journal of Respirology2013，3，1：	0

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

goolge学术搜索-维普

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1　渝公网安备 50019002500403号　违法和不良信息举报中心

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费